Print Page | Sign In | Join Today
News & Press: Company News

HSRL and VPS Merge to form new company, StageBio

Tuesday, March 12, 2019  
Share |
Histo-Scientific Research Laboratories, Inc. (HSRL), a leading provider of research and preclinical histology, pathology, and archiving services, announced the business’ rebranding following the merger with Vet Path Services (VPS) and the accompanying growth investment from Ampersand Capital Partners. The company will now be known as StageBio.

“Over the past 20 years, HSRL has built a strong reputation for quality and reliability and we are excited to maintain our position in the market as a trusted provider of critical services in the pre-clinical research and development market under a new name,” said Mr. Thomas Galati, StageBio CEO. The rebrand is designed to signify the company’s commitment to expand its service offering for the biopharma, medical device, and contract research industries and unify both HSRL and VPS under one name.

The merger of HSRL and VPS is an example of what is to come for StageBio. The company is now positioned to provide its customers with fully integrated histopathology services including tissue analysis, efficacy determination for new compounds and devices, toxicological evaluation of products subject to FDA approval, detailed pathology reporting for GLP studies, medical device pathology, and immunohistochemistry.

Our Premium Partners

Sign up for our newsletter
800 E. Leigh St.  |  Richmond, Va 23219-1534  |  PH: 804.643.6360  |  Email Us
Stay Connected